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ABSTRACT 42 
Background and Purpose 43 
Fatigue is a common symptom among stroke survivors and in general practice. However, the 44 
clinical significance of fatigue and its relationship to incident stroke is unclear.  The aim of 45 
this study was examine the relationship between self-reported fatigue and the incidence of 46 
stroke in a general population. 47 
Methods  48 
This was a prospective population-based study. The study population was 15,654 men and 49 
women aged 39-79 years recruited in 1993-1997 and followed till March 2016. Fatigue was 50 
assessed at 18 months after baseline using the vitality domain of the Short Form 36 51 
questionnaire (SF36-VT). Cox proportional hazard models were constructed to describe the 52 
prospective relationship between baseline fatigue and incident stroke adjusting for age, sex, 53 
systolic blood pressure, cholesterol, physical activity, smoking status, alcohol consumption, 54 
fruit and vegetable consumption, diabetes mellitus, body mass index (BMI), vitamin 55 
supplement use, education level, Townsend deprivation index and occupational social class.  56 
Incident stroke was ascertained using death certificates and hospital record linkage data. 57 
Results  58 
Through 249,248 person years of follow up, 1,509 incident strokes occurred. Participants 59 
who reported the highest level of fatigue (Quartile 4) were more likely to be women, more 60 
likely to be multi-morbid and to perceive their health as fair or poor. We observed 61 
approximately 50% relative risk increase in stroke risk (HR 1.49 (95% CI 1.29-1.71)) in 62 
those who reported highest level of fatigue compared to those who reported the lowest level 63 
of fatigue (Q4 vs. Q1). This relationship remained unaltered regardless of anaemia status, 64 
presence or absence of chronic bronchitis, thyroid dysfunction or depression.  65 
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Conclusions 66 
Self-report fatigue assessed by vitality domain of SF-36 predicts risk of future stroke at the 67 
general population level. Identifying and addressing stroke risk factors in those who report 68 
























 Fatigue is defined as a subjective experience involving malaise and an aversion to 92 
mental or physical activity [1]. It is well established that stroke survivors experience 93 
significant fatigue [2]. Furthermore, among the general population fatigue is a common 94 
complaint, featuring in 25% of general practice consultations, and is associated with 95 
increased all-cause and cardiovascular mortality [3,4]. However, there are no studies which 96 
have focused the relationship between fatigue and incident stroke.   97 
 Nonetheless, there is indirect evidence for a relationship between fatigue and incident 98 
stroke. Increased risk of stroke is associated with related factors such as; poor sleep quality 99 
[5-7], chronic stress [8], depression [9] and vital exhaustion (a concept that incorporates 100 
symptoms of both fatigue and anxiety) [10,11]. Furthermore, there are several plausible 101 
mechanisms through which fatigue may influence stroke risk. Fatigue may be ‘cause 102 
specific’, that is, a symptom of a specific disease process with shared risk factors for stroke 103 
such as; cardiac failure, anaemia and thyroid disease [12-14] Fatigue may act as a marker for 104 
a range of subclinical pathological processes relevant to stroke pathogenesis including; 105 
chronic inflammation, metabolic derangement [15,16], damage to the cerebral 106 
microvasculature and neuro-hormonal disturbance [17,18]. Fatigue may also exert a negative 107 
influence on psychosocial function and motivation, thereby reducing physical activity 108 
participation and impacting upon dietary choices [19-21].   109 
  Therefore, the aim of this study was to examine the prospective relationship between 110 
self-reported general fatigue assessed using well validated SF-36 vitality domain and incident 111 
stroke in a large population based study of apparently healthy men and women of the 112 
European Prospective Investigation into Cancer (EPIC)-Norfolk cohort.   113 
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MATERIALS AND METHODS 114 
 Because of the sensitive nature of the data collected for this study, requests to access 115 
the dataset should be made only by qualified researchers trained in human subject 116 
confidentiality protocols and should be directed to the corresponding author. The study 117 
population was drawn from the EPIC-Norfolk study. This is a prospective cohort study of a 118 
sample of 39-79 year olds in the general population in Norfolk, UK. All GP practices were 119 
contacted in the Norfolk area and participants were recruited from the registers of the 35 120 
participating practices between 1993 and 1997. Baseline data were collected at recruitment 121 
using postal questionnaires and participants were followed until death or the latest data 122 
extraction, 2nd of March 2016. A study flow diagram is available in supplementary material, 123 
Figure I. Ethical approval was obtained from the Norwich Ethics Committee.  To be eligible 124 
in the current study, participants were required to give signed informed consent, have no 125 
history of stroke or transient ischaemic attack (TIA) at baseline health check or before the 126 
completion of the SF36-VT questionnaire, which was collected 18 months after enrolment. 127 
Participants were also required to have complete data for all key confounders (cholesterol 128 
levels, smoking status, systolic blood pressure and body mass index). All data were analysed 129 
anonymously. Due to hospital record and stroke register linkage outcome data were available 130 
for all patients. Further details concerning the recruitment methods of the EPIC-Norfolk 131 
study have been described in detail elsewhere [22]. 132 
 Participants were asked to complete the Short Form 36 (SF36) questionnaire 18 133 
months after enrolment. Of the eight domains within the SF36 the vitality domain (SF36-VT) 134 
was used as the method for the evaluation of self-reported fatigue. This method has been 135 
validated against comparable generic health surveys (such as the Nottingham health 136 
questionnaire) in studies of both diseased and general populations [23, 24]. Participants were 137 
asked to rate “how much of the time over the past 4 weeks… 1) Did you feel full of life? 2) 138 
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Did you have a lot of energy? 3) Did you feel worn out? 4) Did you feel tired?” Participant 139 
responses were collated and transformed into a scale ranging from 1-100 and divided into 140 
vitality quartiles designated 1-4, with quartile 1 representing the group with the most vitality 141 
(henceforth referred to as the least fatigued quartile) and quartile 4 representing the group 142 
with the least vitality (henceforth referred to as the most fatigued quartile).  143 
 Incident stroke was ascertained by identifying the ICD 9 codes, 430–438 or ICD 10, 144 
60–69 on death certificates and hospital record linkage data through East Norfolk 145 
Commission Record (ENCORE). This method has been shown to be highly sensitive and 146 
specific for stroke case ascertainment [25]. Covariates commonly associated with fatigue and 147 
stroke in general practice were assessed at baseline. Height, weight and systolic blood 148 
pressure were measured at the first health check (1993-1997). Body mass index was 149 
calculated using the formula (weight[kg]/(height[m2]) and categorised according to World 150 
Health Organisation definitions. Non-fasting blood samples were also collected, including 151 
non-fasting cholesterol, TSH (values >4.0 mU/l were considered indicative of low thyroid 152 
dysfunction) and haemoglobin (anaemia was defined as Hb <14.0 g/dL in men and <12.0 153 
g/dL in women). All covariates were collected by trained staff according to standardised 154 
protocols within the EPIC Norfolk study [22]. 155 
 The Health and Lifestyle questionnaire was administered at baseline and included 156 
detailed questions on demographic information, health behaviours and past medical history. 157 
Social class was categorised according to the Registrar General’s occupation classification 158 
scheme and sub-divided into manual or non-manual categories. Education status of 159 
participants was defined according to completion of secondary education examinations 160 
(O’level or A’level) or degree status. Participants were asked to describe their smoking habits 161 
and classified as current, non-current and never smokers. Baseline comorbidities were 162 
assessed through the question ‘Has your doctor ever told you have the following?’ followed 163 
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by a list of conditions which included cancer, diabetes, heart attack and stroke. Medication 164 
use was also captured using this survey. Use of antidepressant medications was used to 165 
identify those individuals with comorbid depression. In addition, the EPIC Physical Activity 166 
Questionnaire (EPAQ2) was used to categorise individuals as inactive, moderately inactive, 167 
moderately active or active and the EPIC Food Frequency Questionnaire was used to quantify 168 
participant’s intake of fruit, vegetables and alcohol. 169 
Data were analysed using SPSS version 25.0 (SPSS Inc., Chicago, IL, USA). 170 
Descriptive statistics are presented for the sample across fatigue quartiles, quartile one (Q1) 171 
represents SF36 scores 100-76, quartile two (Q2) represents SF36 scores 75-66, quartile 3 172 
(Q3) represents SF36 scores 65-51 and quartile 4 (Q4) represents SF36 scores 50-0. Sample 173 
characteristics was compared between fatigue quartiles using the ANOVA test for normally 174 
distributed data, Kruskal-Wallis test for non-normally distributed data and Chi-squared test 175 
for categorical data. The association between covariates and incident stroke was tested using 176 
the same methods. Potentially significant confounders (using 80% significance level) and 177 
clinically relevant stroke risk factors were chosen and brought forward into the final models. 178 
Despite evidence of an association between physical and social functioning domains of the 179 
SF36 and stroke, these were not included in the final models due to a high level of 180 
collinearity with fatigue scores. Cox proportional hazards models were constructed to 181 
examine the association between fatigue (defined as a reduced vitality reported using the 182 
SF36-VT) and incident stroke using the first quartile (least fatigued group) as the reference 183 
category. The first of these was unadjusted (model A). The second included the traditional 184 
risk factors for stroke; age, sex, systolic blood pressure, cholesterol, self-reported diabetes 185 
mellitus, body mass index (BMI) (model B). Behavioural risk factors were added in the 186 
subsequent model, including; self-reported smoking status, alcohol intake, fruit and vegetable 187 
consumption and physical activity (model C). The penultimate model additionally included 188 
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measures of socioeconomic status; education, social class, Townsend Score (model D). The 189 
final model included all elements of model D plus vitamin supplement usage (model E). 190 
Effect sizes are expressed as hazard ratios (HR) with 95 % confidence intervals (CI).  191 
Sensitivity analysis were carried out by excluding participants who experienced 192 
stroke in the first two years of the study to rule out reverse causality. In addition, two 193 
additional models were created further adjusting for conditions that may cause fatigue, model 194 
F which is model E + haemoglobin values and model H which is model E + comorbidities 195 
(cancer, chronic bronchitis, past-history of myocardial infarction).  Stratified analyses were 196 
carried out to examine the impact of presence or absence of co-morbidities that cause fatigue 197 
(anaemia, cancer and COPD) and by factors previously found to affect the association 198 
between vital exhaustion and stroke (sex and smoking status). Finally, the analysis was 199 
carried out for specific stroke subtype (ischaemic and haemorrhagic) and outcome (fatal and 200 
non-fatal stroke). A Kaplan Meier curve was constructed to examine the relationship between 201 
fatigue and incident stroke over time. The relationship between the vitality and all other 202 
domains within the SF36 was examined using Spearman rank correlation.  203 
RESULTS 204 
 In total 25,636 participants attended the baseline health assessment, of these 7536 205 
were excluded due to missing SF36 vitality data. This was because not all participants who 206 
returned SF36 at 18 months after enrolment attended health assessment and vice versa. A 207 
further 375 were excluded due to prevalent stroke and 2071 were excluded due to missing 208 
data for key confounders. Most variables were missing data for less than 1% of participants, 209 
however cholesterol values and fruit and vegetable intake were missing for a larger 210 
proportion. Variables with a high proportion (>10%) of missing data not included in the 211 
principle analysis including; haemoglobin levels and thyroid function (quantified by thyroid 212 
stimulating hormone). In total 15,654 participants were included in the analysis (see Figure 213 
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1). There was no material difference between the baseline characteristics of the participants 214 
included and those who were excluded (Supplementary Table I). In this sample, there were a 215 
total of 1,509 cases of incident stroke captured through 249,248 person years of follow-up 216 
(mean 17.77 years). Outcome data were available for all participants. SF36 vitality scores 217 
were correlated with all other SF36 domains. However, the correlation was strongest for the 218 
relationship between fatigue and mental health domains (mental health component summary 219 
score Spearman’s rho= 0.64, p=0.000) and less for physical domains (physical component 220 
summary score rho=0.458, p=0.000) (see Supplementary table II). 221 
 Table 1 shows the baseline characteristics across the fatigue quartiles. Participants 222 
who reported the greatest level of fatigue (quartile 4) were more likely to be female and more 223 
likely to be obese or overweight. Participants in this group were more likely to have 224 
comorbidities including COPD, diabetes mellitus, history of cancer and cardiovascular 225 
disease. There was no significant difference between the mean ages across four quartiles. 226 
Higher fatigue score was also associated with lower Townsend score and educational 227 
attainment. Poor scores within physical and social functioning domains of the SF36 were 228 
highly correlated with fatigue and incident stroke. Self-reported general health was also worst 229 
in those who reported the highest level of fatigue. 230 
 Figure 1 illustrates the unadjusted relationship between stroke incidence and fatigue 231 
quartile, fatigue was associated with an excess risk of stroke throughout the follow up period. 232 
Table 2 shows results of the Cox proportional hazards models. The hazard ratio for incident 233 
stroke was 1.49 (95% CI 1.29-1.71) in the fully adjusted model (model E). This increased to 234 
1.59 (95% CI 1.35-1.86) when analyses were confined to the ischaemic stroke. Exclusion of 235 
those who had stroke within 2 years of reporting fatigue did not change the effect size. The 236 
effect of fatigue in haemorrhagic stroke was limited (a non-significant 12% increase in post 237 
estimate hazard ratio). The effect of fatigue on stroke fatality also did not reach the level of 238 
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statistical significance. Additional adjustment for comorbidities in Model G (cancer, COPD, 239 
prior myocardial infarction, thyroid dysfunction and anaemia) marginally increased the effect 240 
size to 1.55 (1.26-1.91) (see Table 1).  241 
 The effect size was similar between never smokers compared to smokers, and 242 
between men and women. The analysis was also stratified by comorbidities which are known 243 
to be associated with fatigue. The presence of anaemia, depression, thyroid dysfunction, 244 
COPD and cancer did not attenuate the effect of fatigue, although the precision of all 245 
estimates was affected by the low event rates in these subgroups. However, the effect size 246 
was lower amongst participants who had previously experienced myocardial infarction 247 
HR1.27 [95% CI 0.60-2.70]) and sub-analysis of participants reporting poor or moderate 248 
health (HR 1.16 [95% CI 0.93-1.44]) (see Supplementary Table III). 249 
DISCUSSION 250 
 In this population-based prospective cohort study we demonstrate the independent 251 
association between self-reported fatigue and the risk of incident stroke in a general 252 
population. This effect was large and remained persistant over more than 20 years of follow 253 
up. It represented a 59% increase in the relative risk of ischaemic stroke in those who 254 
reported greatest fatigue (Q4) compared to those in the lowest level of fatigue with a clear 255 
linear dose response relationship.  Those in the most fatigued group were more likely to; be 256 
female, suffer from comorbidities and report lower scores in all domains of the SF36, 257 
particularly the mental health domain. To the best of our knowledge, this is the first report 258 
demonstrating the link between self-reported fatigue and stroke in a general population which 259 
may have clinical implication in preventing stroke.  260 
 Notwithstanding the paucity in research into general fatigue, there is some evidence 261 
that supports the plausibility of our findings. Several have evaluated the relationship between 262 
exhaustion or vital exhaustion (a triad of depression, demoralisation and irritability) and 263 
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stroke [10]. Three of these studies were evaluated within a meta-analysis of 17 papers 264 
concerning vital exhaustion and cardiovascular events. This concluded that vital exhaustion 265 
increased the risk of all cardiovascular disease by 53% and of stroke by 46% although the 266 
latter relationship was not statistically significant [26]. The studies were limited by low event 267 
rates and this association was found only to be significant amongst women and smokers 268 
[10,11, 27]. A separate study concerning vital exhaustion in Russia found that exhausted men 269 
aged 25–64-years were at a substantially higher risk of stroke than non-exhausted men over 270 
14 years of follow-up (HR 2.6) [28]. Furthermore, we have previously shown that fatigue 271 
increased the hazards of cardiovascular mortality by 45% [4]. 272 
 There is also evidence available to support the association between the factors that 273 
underlie fatigue and incident stroke. Fatigue therefore, may be used as an umbrella concept 274 
that can capture the experience of multiple interrelated adverse health states relevant to the 275 
pathogenesis of stroke. Fatigue in this study was associated with worse mental and physical 276 
health. It has previously been established that fatigue may be a result of sleep disorder [29] or 277 
psychosocial stress [30], which have been associated with incident stroke under various 278 
labels including: non-restorative sleep [5-7] work pressure [31], major life events [11], 279 
chronic stress [8] and depression [9]. A meta-analysis of 14 studies involving a total of 280 
10,130 strokes found a 33% increased risk of incident stroke in those reporting perceptions of 281 
psychosocial stress [32]. The mechanisms behind these associations are unclear, however it 282 
has been proposed that both poor sleep and chronic stress may lead to measurable 283 
disturbances in normal homeostatic mechanisms, such as endocrine dysfunction, metabolic 284 
syndrome [33] and hypertension [34] which may contribute to the pathogenesis of stroke. 285 
Furthermore, psychosocial stress and poor sleep may mediate stroke risk by adversely 286 
affecting dietary choices and participation in physical activity [20, 21].  287 
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  In addition to the role of psychosocial factors it is likely that poor physical health 288 
accounts for a portion of the observed relationship between fatigue and stroke. In this context 289 
fatigue may be a useful composite marker for the presence and severity of comorbidity. 290 
Furthermore, fatigue may be a symptom of disturbances of physical function that are often 291 
undiagnosed and unaccounted for in risk quantification such as metabolic syndrome [15] and 292 
chronic inflammatory states [16]. It is also possible that fatigue may be a premonitory 293 
symptom of stroke. For example, there is some evidence that cardiovascular events are 294 
preceded by fatigue [17] and it is possible that stroke sufferers experience subclinical infarcts 295 
prior to the major event, resulting in fatigue [35, 36]. However, exclusion of incident strokes 296 
occurring within the first two years of follow up reduces the likelihood that our results are 297 
due to reverse causality. 298 
 Our study has several strengths. Unlike previous studies on this topic we chose a 299 
broad definition of fatigue which could be assessed using an intuitive tool (SF36-VT). The 300 
SF36 has been extensively evaluated in the British population and has excellent internal 301 
consistency [24, 37, 38, 39, 40], test re-test reliability (correlation coefficient 0.84) [38] and 302 
construct validity when compared with alternative fatigue scales [24, 40] While 303 
comprehensive fatigue scales may allow fatigue to be quantified with greater precision, the 304 
brevity and simplicity of this scale may make it a more suitable tool in clinical practice [40]. 305 
This study drew from a large population and included a higher number of incident strokes 306 
than observed in previous studies. Furthermore, the detail available in this prospective cohort 307 
allow us to control for various relevant confounders and examine the mediating effect of 308 
known causes of fatigue including anaemia and depression. We also had complete follow up 309 
in through data linkage and use of disease registries.  Most importantly, participants in our 310 
cohort were recruited from general practice registries similar baseline characteristics to the 311 
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national population (with the exception of a slightly lower prevalence of smokers) [25]. 312 
Therefore, it is likely that these results are applicable across other Caucasian populations.  313 
 There are a number of noteworthy limitations to this study. As a prospective cohort 314 
study, we cannot exclude the impact of residual confounding by known or unknown 315 
confounders. Secondly, it should be noted that this study measured fatigue only at baseline 316 
and cannot account for changes in fatigue status or severity over time. However, such random 317 
variation is likely to result in an underestimation of the effect size. We excluded a proportion 318 
due to missing data on SF-36VT, however, there was no material difference between sample 319 
characteristics of those included and excluded. We didn’t distinguish individuals with chronic 320 
fatigue syndrome, which is a distinct disease entity and these individuals may have different 321 
risk profile than the general population.  While causality cannot be directly implied, we have 322 
demonstrated the prospective relationship through several sensitivity and mediating analyses 323 
as well as provided plausible biomedical causal mechanisms.  324 
 The increase in ischaemic stroke risk associated with fatigue is substantial. However, 325 
at present, fatigue is a neglected symptom in clinical practice [1,4]. Therefore, these findings 326 
may provide impetus for consideration of fatigue as an important risk marker. Unlike 327 
traditional biomarkers, fatigue may facilitate a more holistic evaluation of an individual’s 328 
wellbeing [29] and could be considered alongside other ‘non-disease specific’ facets of health 329 
such as cognitive impairment, isolation, frailty and polypharmacy [37, 38]. This may identify 330 
individuals with a high cardiovascular risk who would be overlooked by existing scoring 331 
systems and facilitate early detection of modifiable risk factors [41].  332 
Furthermore, fatigue itself could be approached as a modifiable risk factor [4]. There are 333 
a number of effective management strategies for fatigue designed for specific patient 334 
populations that may be applicable for the general population. Non-pharmacological 335 
management, such as graded exercise programs, fatigue management education and 336 
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psychotherapy have been found to be safe and effective in multiple chronic conditions [42-337 
45]. Insomnia may also be treated effectively using similar measures [46]. Pharmacological 338 
intervention, be it through de-prescribing culprit drugs or prescribing drugs such as 339 
antidepressants are likely to be less widely applicable [42, 44].  At a societal level, addressing 340 
issues such as income inequality and long working hours may be important to address root 341 
causes of fatigue [47, 48]. Further research is required to examine the potential effect of 342 
fatigue treatment on preventing stroke. 343 
CONCLUSIONS 344 
 The recognition that fatigue is an important adverse health state, may be used to 345 
improve risk quantification in stroke and incentivise physicians to identify and treat relevant 346 
risk factors in fatigued individuals. Therefore, assessment of fatigue via SF-36 vitality 347 
domain as part of may provide an opportunity to reduce future burden of stroke. Future 348 
studies should focus on further elucidating the mechanisms underlying fatigue in the general 349 
population. We recommend that fatigue be considered as part of a holistic assessment of 350 
cardiovascular disease risk in general practice.  351 
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FIGURE 1 546 
 547 
 548 
Years 0 3 6 9 12 15 18 21 
Total 
Event/N 
72/15654 92/15337 143/14899 186/14351 241/13690 302/12897 332/11987 140/7770 
Q1 
Event/N 
17/3879 16/3822 27/3735 34/3635 48/3502 84/3316 88/3087 31/2012 
Q2 
Event/N 
9/3007 8/2973 27/2918 30/2706 49/2557 47/2397 65/1566 31/253 
Q3 
Event/N 
17/4077 36/4010 34/3867 45/3727 62/3544 77/3337 87/3112 42/1964 
Q4 
Event/N 
29/4691 32/4532 55/4379 77/4175 82/3938 94/3687 92/3391 36/2228 
 549 
Kaplan Meier graph and lifetable demonstrating stroke events vs number at risk in 550 











Table 1: Baseline sample characteristics by SF36-VT quartiles of 15,654 EPIC-Norfolk participants (1993-1997). 561 









Total N (%) 3879 3007 4077 4691 
Age (years) mean (SD) 59.25 (8.67) 58.97 (0.09) 59.29 (9.25) 58.80 (9.42) 
Sex     
Male N (%) 1935 (49.88) 1380 (45.89) 1770 (43.41) 1821 (38.82) 
Female N (%) 1944 (50.12) 1627 (54.11) 2307 (56.59) 2870 (61.18) 
Body Mass Index (kg/m2)     
< 18.5 12 (0.31) 12 (0.40) 19 (0.47) 31 (0.66) 
18.5 – 24.9 1701 (43.85) 1275 (42.40) 1599 (39.22) 1815 (38.69) 
25.0 – 30.0 1783 (45.96) 1376 (45.76) 1861 (45.65) 2021 (43.08) 
Over 30.0 383 (9.87) 344 (11.44) 598 (14.67) 824 (17.57) 
Systolic BP (mmHg) mean (SD) 135.38 (17.74) 134.57 (18.04) 134.99 (18.54) 134.47 (18.11) 
 26 
Serum cholesterol (mmol/l) mean (SD) 6.15 (1.12) 6.16 (1.16) 6.18 (1.17) 6.18 (1.16) 
Diabetes Mellitus (self-reported) 64 (1.65) 49 (1.63) 69 (1.69) 130 (2.77) 
Use of antidepressant drugs 75 (1.93) 81 (2.69) 184 (4.51) 400 (8.53) 
Myocardial Infarction (self-reported) 60 (1.55) 67 (2.23) 112 (2.75) 202 (4.31) 
Cancer (self-reported) 167( 4.31) 149 (4.96) 207 (5.08) 332 (7.08) 
COPD (self-reported) 231 (5.96) 209 (6.95) 410 (10.06) 539 (11.49) 
Fruit intake (g/day) median (IQR) 222.55 (196.00) 224.40 (191.55) 217.10 (190.93) 203.90 (191.75) 
Vegetable intake (g/day) median (IQR) 230.55 (157.80) 228.63 (143.68) 229.04 (138.69) 217.12 (141.66) 
Alcohol consumption (g/day) median (IQR) 4.50 (8.50) 4.00 (9.00) 4.00 (8.50) 3.00 (8.00) 
Smoking Status (self-reported)     
Current 372 (9.59) 261 (8.68) 415 (10.18) 599 (12.77) 
Former 1586 (40.89) 1259 (41.87) 1756 (43.07) 1936 (41.27) 
Never 1921 (49.52) 1487 (49.45) 1906 (46.75) 2156 (45.96) 
Physical Activity (self-reported)     
Inactive 858 (22.12) 754 (25.07) 1124 (27.57) 1569 (33.45) 
 27 
Moderately Inactive 1104 (28.46) 931 (30.96) 1201 (29.46) 1372 (29.25) 
Moderately Active 976 (25.16) 720 (23.94) 1035 (25.39) 1009 (21.51) 
Active 941 (24.26) 602 (20.02) 717 (17.59) 741 (15.79) 
Townsend score median (IQR) -2.69 (2.34) -2.81 (2.00) -2.67 (2.63) -2.54 (2.55) 
Social Class     
Professional 280 (7.22) 279 (9.28) 306 (7.51) 310 (6.61) 
Managerial 1563 (40.29) 1176 (39.11) 1558 (38.21) 1678 (35.77) 
Skilled non-manual 636 (16.40) 485 (16.13) 711 (17.44) 828 (17.65) 
Skilled manual 848 (21.86) 665 (22.12) 850 (20.85) 1043 (22.23) 
Semi-skilled manual 444 (11.45) 321 (10.68) 541 (13.27) 647 (13.79) 
Non-skilled 108 (2.78) 81 (2.69) 111 (2.72) 185 (3.94) 
Educational Attainment     
Degree or Higher 545 (14.05) 436 (14.50) 573 (14.05) 606 (12.92) 
A-Level 1673 (43.13) 1282 (42.63) 1665 (40.84) 1863 (39.71) 
O-Level 403 (10.39) 318 (10.58) 439 (10.77) 531 (11.32) 
No Qualification 1258 (32.43) 971 (32.29) 1400 (34.34) 1691 (36.05) 
 28 
Vitamin use 1652 (42.59) 1318 (43.83) 1811 (44.42) 2138 (45.58) 
Anaemia N (%) 767 (29.23) 583 (27.64) 768 (26.6) 844 (25.39) 
 562 
The data presented as mean and (SD) for normally distributed continuous variables, median and interquartile range (IQR) for non-normally 563 
distributed variables, and number (N) and percentage (%) for categorical variables. P values indicate levels of significance across all quartiles, 564 
these were calculated using student’s T test and T test for unequal variance for normally distributed data and the Kruskal-Wallis test for non-565 
normally distributed data. P values for categorical variables were calculated using the Chi squared test. †The following data had missing values: 566 
anaemia (30% missing).  567 
 568 
Table 2: Cox proportional hazards model and hazard ratios (with corresponding 95% confidence intervals) for incident stroke of any type, and by 569 
stroke sub-type and fatal strokes in the EPIC Norfolk study. 570 
Hazard Ratios SF-36 vitality score quartiles P value* 










Events/population 345/3879 267/3007 400/4077 497/4691 1509/15654 
 29 
Model A HR (95 % CI) 1.00 1.01 (0.86-1.18) 1.15 (1.00-1.33) 1.29 (1.13-1.48) <0.001 
Model B HR (95 % CI) 1.00 1.02 (0.87-1.20) 1.19 (1.03-1.38) 1.49 (1.30-1.72) <0.001 
Model C HR (95 % CI) 1.00 1.04 (0.88-1.22) 1.20 (1.03-1.38) 1.49 (1.29-1.71) <0.001 
Model D HR (95 % CI) 1.00 1.04 (0.88-1.22) 1.19 (1.03-1.38) 1.48 (1.28-1.70) <0.001 
Model E HR (95 % CI) 1.00 1.04 (0.89-1.22) 1.20 (1.04-1.39) 1.49 (1.29-1.71) <0.001 
Model F HR (95 % CI)* 1.00 1.02 (0.84-1.25) 1.16 (0.96-1.39) 1.52 (1.27-1.80) <0.001 
Model G HR (95 % CI)* 1.00 1.12 (0.88-1.41) 1.20 (0.96-1.49) 1.55 (1.26-1.91) <0.001 
Ischaemic stroke 
Events  272/3879 218/3007 327/4077 416/4691 1233/15654 
Model A HR (95 % CI) 1.00 1.04 (0.87-1.24) 1.197 (1.02-1.41) 1.37 (1.18-1.60) <0.001 
Model B HR (95 % CI) 1.00 1.06 (0.89-1.27) 1.233 (1.05-1.45) 1.59 (1.36-1.85) <0.001 
Model C HR (95 % CI) 1.00 1.08 (0.90-1.29) 1.244 (1.06-1.46) 1.59 (1.36-1.86) <0.001 
Model D HR (95 % CI) 1.00 1.08 (0.90-1.29) 1.241 (1.06-1.46) 1.58 (1.35-1.84) <0.001 
Model E HR (95 % CI) 1.00 1.08 (0.91-1.29) 1.247 (1.06-1.47) 1.59 (1.36-1.86) <0.001 
Haemorhagic stroke 
Events/ Population 73/3879 49/3007 73/4077 81/4691 276/15654 
 30 
Model A HR (95 % CI) 1.00 0.87 (0.61-1.25) 0.99 (0.72-1.37) 0.99 (0.72-1.36) 0.87 
Model B HR (95 % CI) 1.00 0.89 (0.62-1.28) 1.03 (0.75-1.43) 1.14 (0.83-1.57) 0.50 
Model C HR (95 % CI) 1.00 0.88 (0.62-1.27) 1.02 (0.73-1.41) 1.11 (0.80-1.53) 0.67 
Model D HR (95 % CI) 1.00 0.88 (0.61-1.27) 1.02 (0.74-1.41) 1.11 (0.81-1.54) 0.65 
Model E HR (95 % CI) 1.00 0.88 (0.62-1.27) 1.02 (0.74-1.41) 1.12 (0.81-1.55) 0.64 
Fatal stroke 
Events/ Population 145/3879 95/3007 162/4077 216/4691 618/15654 
Model A HR (95 % CI) 1.00 0.95 (0.73-1.23) 1.01 (0.80-1.26) 1.22 (0.99-1.50) 0.106 
Model B HR (95 % CI) 1.00 0.91 (0.70-1.18) 0.96 (0.76-1.20) 1.23 (1.00-1.53) 0.030 
Model C HR (95 % CI) 1.00 0.89 (0.69-1.16) 0.88 (0.70-1.11) 1.14 (0.92-1.42) 0.065 
Model D HR (95 % CI) 1.00 0.93 (0.71-1.21) 0.89 (0.71-1.13) 1.16 (0.93-1.45) 0.078 
Model E HR (95 % CI) 1.00 0.93 (0.71-1.21) 0.89 (0.71-1.12) 1.16 (0.93-1.44) 0.083 
 571 
Model A: unadjusted; Model B: age, sex (first man) systolic, BP, cholesterol, DM (first), BMI; Model C: B + smoking, alcohol intake, fruit and 572 
vegetable intake, physical activity; Model D: C+ education, social class (first), Townsend Score; Model E: D +vitamin use; Model F: E + 573 
 31 
haemaglobin levels; Model G: F+prior MI, cancer, chronic bronchitis and high TSH. *Model F and Model G include data with missing values. * 574 
P test for trend across vitality quartiles. 575 
 576 
 577 
 578 
 579 
 580 
